<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04016597</url>
  </required_header>
  <id_info>
    <org_study_id>2019-00226</org_study_id>
    <nct_id>NCT04016597</nct_id>
  </id_info>
  <brief_title>Nitric Oxide Lung Diffusing Capacity in Healthy, Non-smoking Adults</brief_title>
  <official_title>Comparison of Two Commercially Available Devices to Measure Nitric Oxide Lung Diffusing Capacity in Healthy, Non-smoking Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The measurement of nitric oxide lung diffusing capacity (DLNO) has been recently
      standardised. To date, two pulmonary function devices are commercially available and are used
      for the measurement of DLNO. No previous study assessed differences in gas exchange outcomes
      (e.g., DLNO values) between both devices.

      The aim of this project is to compare two commercially available devices that measure lung
      diffusing capacity for nitric oxide (DLNO).

        1. &quot;MasterScreenTM&quot; (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany

        2. &quot;HypAir&quot; (&quot;HA&quot;, Medisoft, Dinant, Belgium).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a single-center, crossover study conducted at the University Hospital Zurich, Switzerland,
      35 healthy, non-smoking adults (&gt;=18 years) will be invited to perform DLNO measurements in
      random order using the MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and
      HypAir (Medisoft, Dinant, Belgium) devices during one study visit.

      The order of the tests on the MasterscreenTM and HypAir devices will be randomly allocated
      using central randomisation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Actual">January 31, 2020</completion_date>
  <primary_completion_date type="Actual">January 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in nitric oxide lung diffusing capacity (mL/min/mmHg)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in carbon monoxide lung diffusing capacity (mL/min/mmHg)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in Alveolar volume (L)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in inspiratory volume (L)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in breath-hold time (s)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in inspired concentrations for nitric oxide (in %)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in expired concentrations for nitric oxide (in %)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in inspired concentrations for carbon monoxide (in %)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in expired concentrations for carbon monoxide (in %)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in inspired concentrations for helium (%)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in expired concentrations for helium (%)</measure>
    <time_frame>1 day</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in inspired concentrations for oxygen (%)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in expired concentrations for oxygen (%)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">35</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Lung diffusing capacity measurements</arm_group_label>
    <description>Participants perform single-breath lung diffusing capacity measurements in random order during one study visit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Jaeger Masterscreen TM</intervention_name>
    <description>Single-breath nitric oxide lung diffusing capacity</description>
    <arm_group_label>Lung diffusing capacity measurements</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HypAir Medisoft</intervention_name>
    <description>Single-breath nitric oxide lung diffusing capacity</description>
    <arm_group_label>Lung diffusing capacity measurements</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy people
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Age 18 years and older

        Exclusion Criteria:

          -  Previous thoracic surgery

          -  Smoking

          -  Chronic lung disease (e.g., asthma bronchiale, COPD)

          -  Forced expiratory volume in 1s and/or forced vital capacity below the lower limit of
             normal based on spirometry [Quanjer et al. Eur Respir J 2005]

          -  Current respiratory infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Radtke, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich, EBPI, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Zurich and University Hospital of Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <results_reference>
    <citation>Zavorsky GS, Hsia CC, Hughes JM, Borland CD, Gu√©nard H, van der Lee I, Steenbruggen I, Naeije R, Cao J, Dinh-Xuan AT. Standardisation and application of the single-breath determination of nitric oxide uptake in the lung. Eur Respir J. 2017 Feb 8;49(2). pii: 1600962. doi: 10.1183/13993003.00962-2016. Print 2017 Feb.</citation>
    <PMID>28179436</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>July 4, 2019</study_first_submitted>
  <study_first_submitted_qc>July 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2019</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diffusing capacity</keyword>
  <keyword>reliability</keyword>
  <keyword>healthy</keyword>
  <keyword>adults</keyword>
  <keyword>nitric oxide</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

